International Projects
BETTER UNDERSTANDING OF RISK FACTORS AND PROGRESSION OF MELANOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS TO IMPLEMENT HEALTH CARE STRATEGIES (MELCAYA)
Scientific Director: Prof. Daniela Massi
Funding agency: European Community (Horizon Europe - Mission Cancer)
Reference year: 2022
Start date: December 1, 2022
End date: November 30, 2026
Project type: Horizon Europe - Mission Cancer
MELCAYA is a European project investigating the causes, mechanisms, and progression of melanoma in young people, with the goal of creating more effective prevention and treatment strategies based on scientific evidence and tailored to pediatric and adolescent specificities
Targeting the nectin family to boost cancer immunity (TENACITY)
Scientific Director: Prof. Daniela Massi
Funding agency: European Community
Reference year: 2023
Start date: August 15, 2023
End date: August 31, 2026
Project type: other joint-management programs funded by MUR
The research aims to develop new immuno-oncology therapies that enhance T and NK cell activity against tumors by selectively targeting Nectins and their immune receptors
Joint Action on CARdiovascular diseases and DIabetes (JACARDI)
Scientific Director: Prof. Chiara Lorini
Funding agency: European Community through the EU4Health European Program
Reference year: 2023
Start date: November 1, 2023
End date: December 31, 2027
Project type: EU4Health
The research aims to reduce the burden of cardiovascular diseases (CVD) and diabetes (DM) in EU countries by acting across the entire patient pathway, from prevention to screening and disease management
Joint Action EU4H-2023-JA-03 Healthier Together EU NCD initiative–Chronic respiratory diseases (JARED)
Scientific Director: Prof. Chiara Lorini
Funding agency: European Community through the EU4Health European Program
Reference year: 2024
Start date: December 1, 2024
End date: November 30, 2027
Project type: EU4Health
The research aims to reduce the burden of chronic respiratory diseases (CRD) – such as asthma, COPD, interstitial and occupational lung diseases – through prevention, early diagnosis, digital technologies, and the improvement of care pathways
Spatial single-cell omics research training for melanoma precision medicine (SPACE-MEL)
Scientific Director: Prof. Daniela Massi
Funding agency: European Community (Horizon Europe - MSCA)
Reference year: 2026
Start date: September 1, 2026
End date: August 30, 2030
Project type: Horizon Europe - MSCA
The aims of the research are: to train a new generation of researchers capable of using single-cell and spatial omics technologies to map melanoma at the cellular and spatial level, understand its heterogeneity, and improve diagnosis, prognosis, and personalized therapies
Last update
31.07.2026